CSTL
Castle Biosciences Inc
33.00$
-1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.1% | 65.2% | 64.5% | 65.7% | 67.0% | 67.8% | 69.6% | 64.0% | 63.5% | 62.4% | 60.0% | 60.8% | |
| 20.9% | 21.8% | 18.1% | 17.6% | 18.5% | 22.5% | 17.9% | 15.1% | 15.2% | 20.2% | 11.6% | 11.1% | |
| 52.7% | 53.6% | 52.2% | 53.3% | 54.4% | 55.2% | 54.8% | 50.7% | 51.1% | 51.8% | 47.8% | 47.5% | |
| 8.5% | 8.4% | 9.3% | 9.4% | 9.8% | 9.6% | 11.2% | 9.6% | 8.8% | 7.5% | 7.7% | 8.6% | |
| 1.3% | 1.8% | 1.7% | 1.6% | 1.3% | 1.5% | 1.4% | 1.5% | 1.5% | 1.8% | 1.9% | 1.9% | |
| 2.5% | 2.4% | 2.3% | 2.2% | 2.1% | 2.0% | 2.1% | 2.0% | 1.9% | 1.8% | 2.0% | 1.9% | |
| 25.0% | 23.5% | 22.8% | 21.0% | 19.4% | 18.0% | 13.4% | 17.2% | 16.2% | 15.4% | 15.8% | 15.0% | |
| 11.5% | 13.7% | 12.2% | 13.0% | 14.3% | 14.2% | 12.2% | 16.4% | 17.0% | 18.6% | 15.8% | 16.2% | |
| 8.3% | 10.5% | 7.0% | 8.1% | 8.6% | 9.3% | 7.4% | 9.3% | 9.8% | 11.9% | 8.9% | 10.1% | |
| 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% | 0.6% | 0.3% | 0.3% | 0.5% | 0.8% | |
| 1.6% | 2.3% | 2.0% | 2.0% | 1.3% | 1.3% | 1.7% | 2.4% | 2.2% | 3.2% | 2.7% | 1.7% | |
| – | – | 2.2% | 2.1% | 1.9% | 1.8% | 1.8% | 1.5% | 1.8% | 1.7% | 1.5% | 1.3% | |
| 88.5% | 86.3% | 87.8% | 87.0% | 85.7% | 85.8% | 87.8% | 83.6% | 83.0% | 81.4% | 84.2% | 83.8% | |
| -49.5% | -48.2% | -48.2% | -43.5% | -40.8% | -37.7% | -45.0% | -40.7% | -39.4% | -38.8% | -43.6% | -42.9% | |
| 6.2% | 6.0% | 6.0% | 5.9% | 5.7% | 5.7% | 5.7% | 5.4% | 5.2% | 5.1% | 5.5% | 5.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.